New Law Brief

Comply Today!

Atlanta, GA, November 8. Biomedical Disposal, Inc. (Biomed) commends President Clinton for signing The Needlestick Safety and Prevention Act. The Act requires the Occupational Safety and Health Administration to change the federal bloodborne pathogen standard to require employers to revise their work practices and to use "safer medical devices" that reduce or eliminate accidental needlesticks. Also, needle destruction devices were cited as an example of "safer medical devices" that can reduce accidental needlestick injuries. In fact, in order to ensure passage, Charles N. Jeffress, OSHA Administrator, wrote "OSHA has allowed, and intends to continue to allow, employers to use sharps destruction devices to help reduce the risk of needlestick injuries."

"The Congress has acted on this important public health issue – protecting the nation’s healthcare workers from the deadly scourge of HIV and hepatitis," said [redacted], CEO of Biomed. "Also, Congress recognized that safety requires a comprehensive approach – eliminating the behaviors that cause accidents as well as using devices that have proven to reduce accidental needlesticks."

Biomed offers a comprehensive array of products and services that make the healthcare workplace safer. NICS_x™ is a proprietary, Internet based management system that can put a facility into immediate compliance with the new bloodborne pathogen standard, and is based on methods proven in independent studies to nearly eliminate accidents in various industrial settings. Sharp_XÒ is an FDA approved Class III needle destruction device that proved its ability to reduce accidental needlesticks through clinical trials. Additional safety products are scheduled for introduction in the next few months.

Biomed’s products are complimentary and competitive to those offered by Becton Dickinson and Company (NYSE:BD), Med-Design Corporation (NASDAQ:MEDC), Bio-Plexus Inc. (NASDAQ:BPLX) and Medisys Technologies, Inc. (OTCBB:SCEP).

For information go to:

www.nicsx.com